ATRA

Atara Biotherapeutics Inc

May 15 • 04:00PM ET

9.58

-0.01 -0.10 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: FATE ALLO CABA KYTX AUTL

| Held by: VTI VXF IWC DCOR DFAC BTEC DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.88	Insider Own	40.61%	Shs Outstand	8.51M	Perf Week	14.87%
Market Cap	86.32M	Forward P/E	185.55	EPS next Y	0.05	Insider Trans	2.91%	Shs Float	5.83M	Perf Month	82.82%
Enterprise Value	129.52M	PEG	-	EPS next Q	-0.24	Inst Own	48.52%	Short Float	5.25%	Perf Quarter	115.28%
Income	-9.47M	P/S	3.73	EPS this Y	-126.68%	Inst Trans	0.84%	Short Ratio	0.20	Perf Half Y	-23.18%
Sales	23.14M	P/B	-	EPS next Y	107.53%	ROA	-23.08%	Short Interest	0.31M	Perf YTD	-47.04%
Book/sh	-4.38	P/C	10.33	EPS next 5Y	-	ROE	-	52W High	19.15 -49.96%	Perf Year	25.89%
Cash/sh	0.93	P/FCF	-	EPS past 3/5Y	- -	ROIC	-75.60%	52W Low	3.92 144.39%	Perf 3Y	-82.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	23.85% -	Gross Margin	96.12%	Volatility	15.76% 13.63%	Perf 5Y	-97.44%
Dividend TTM	-	EV/Sales	5.60	EPS Y/Y TTM	76.14%	Oper. Margin	-26.42%	ATR (14)	1.12	Perf 10Y	-97.50%
Dividend Ex-Date	-	Quick Ratio	2.16	Sales Y/Y TTM	-88.41%	Profit Margin	-40.91%	RSI (14)	67.89	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.16	EPS Q/Q	-108.40%	SMA20	46.98%	Beta	-0.03	Target Price	11.67
Payout	0.00%	Debt/Eq	-	Sales Q/Q	-99.47%	SMA50	66.65%	Rel Volume	0.14	Prev Close	9.59
Employees	14	LT Debt/Eq	-	Earnings	May 12 AMC	SMA200	-6.09%	Avg Volume	1.56M	Price	9.58
IPO	Oct 16, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	11.99% -82.21%	Trades		Volume	225,269	Change	-0.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)